These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19433389)

  • 1. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
    Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
    Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
    Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
    Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
    Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
    Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
    Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
    Pal A; Provenzano E; Duffy SW; Pinder SE; Purushotham AD
    Br J Surg; 2008 Mar; 95(3):302-9. PubMed ID: 17876750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breast cancer.
    Nadeem RM; Gudur LD; Saidan ZA
    Clin Breast Cancer; 2014 Aug; 14(4):272-9. PubMed ID: 25037530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the likelihood of nonsentinel lymph node metastases in triple negative breast cancer patients with a positive sentinel lymph node: Turkish Federation of Breast Disease Associations protocol MF09-01.
    Ozbas S; Ozmen V; Igci A; Muslumanoglu M; Ozcinar B; Balkan M; Aydogan F; Canda T; Harmancioglu O; Aksaz E; Gulluoglu BM; Kayahan M; Ozaslan C; Canturk NZ; Mersin H; Utkan Z; Kocak S; Ulufi N; Polat AK; Andacoglu O; Soran A
    Clin Breast Cancer; 2012 Feb; 12(1):63-7. PubMed ID: 22130034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy.
    Scomersi S; Torelli L; Zanconati F; Tonutti M; Dore F; Bortul M
    Ann Ital Chir; 2012; 83(6):461-8. PubMed ID: 23110902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; Roumen RM
    Ann Surg Oncol; 2012 Jun; 19(6):1841-9. PubMed ID: 22207045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A head to head comparison of nine tools predicting non-sentinel lymph node status in sentinel node positive breast cancer women.
    van den Hoven I; Kuijt G; Roumen R; Voogd A; Steyerberg EW; Vergouwe Y
    J Surg Oncol; 2015 Aug; 112(2):133-8. PubMed ID: 26258749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the sentinel node frozen section result on the probability of additional nodal metastases as predicted by the MSKCC nomogram in breast cancer.
    Jamal MH; Rayment JH; Meguerditchian A; Doi SA; Meterissian S
    Jpn J Clin Oncol; 2011 Mar; 41(3):314-9. PubMed ID: 21149238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients.
    Scow JS; Degnim AC; Hoskin TL; Reynolds C; Boughey JC
    Cancer; 2009 Sep; 115(18):4064-70. PubMed ID: 19517477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer.
    Moghaddam Y; Falzon M; Fulford L; Williams NR; Keshtgar MR
    Br J Surg; 2010 Nov; 97(11):1646-52. PubMed ID: 20641049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.